MedTrace Logo

A Study of Strategies to Improve Schizophrenia Treatment

NCT00156637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2015-04-07

No results posted yet for this study

Summary

The goal of this project is to translate research findings about key aspects of antipsychotic treatment into routine care through a multi-component intervention, focusing on improving two aspects of medication management that are directly linked to patient outcomes: 1) monitoring for potentially serious metabolic side effects of newer antipsychotic medication, and 2) increasing the appropriate use of clozapine for treatment-refractory patients.

Conditions

Interventions

BEHAVIORAL

Team-Based Quality Improvement Intervention

Intervention to improve recommended dosing and side effect monitoring of antipsychotic medications using a team-based quality improvement effort

BEHAVIORAL

Opinion Leader Intervention

Intervention to improve recommended dosing and side effect monitoring of antpsychotic medications using an Opion leader quality improvement effort

BEHAVIORAL

Team Based Quality Improvement

Intervention to increase appropriate use of clozapine through a team based quality intervention.

Sponsors & Collaborators

Principal Investigators

  • Richard R. Owen, MD · Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2007-01-31
Completion
2008-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00156637 on ClinicalTrials.gov